Chris S. Hassan
President and Chief Executive Officer
Chris Hassan is a senior healthcare executive with over 25 years of experience in the field of addiction treatment. He is the President and CEO of Symetria Health®, the country’s first comprehensive evidence-based opioid addiction treatment program, designed to deliver data-validated outcomes that outperform other treatments currently available.
Prior to joining Symetria Health®, Chris co-founded Reckitt Benckiser Pharmaceuticals creating the office-based treatment model for opioid dependence and launching Suboxone®. Subsequently, he served as Chief Executive Officer of Colonial Management Group – the largest chain of opioid addiction treatment centers in the US at the time. He also developed and patented several new opioid product combinations focused on preventing diversion and inadvertent benzodiazepine overdose in patients.
Chris is active on several national panels and corporate boards while also serving as a Huffington Post contributor.